"Asian Countries to Witness Tremendous Growth in Future"

Interview "Asian Countries to Witness Tremendous Growth in Future"

29.04.2013Author / Editor: The interview is conducted by Assistant Editor, PROCESS India, Swati Deshpande. / Dominik Stephan

Sigma-Aldrich has recently opened a Global Shared Services (GSS) Center at Bengaluru. Jason Apter, Vice President & Managing Director Asia Pacific, Sigma Aldrich talks to PROCESS India about company’s GSS Center and plans ahead.

Related Companies

MilliporeSigma SIGMA-ALDRICH Chemie GmbH

MilliporeSigma

MG2 s.r.l.

GIG Karasek GmbH

Linde CryoPlants Ltd.

“We suspect that biosimilars is going to see a very strong future and India is going to be one of the major hubs in this section,” Apter
(Picture: Vogel Business Media)

PROCESS: Can you throw some light on the recently opened Global Shared Services (GSS) Center?

JASON APTER: The newly opened GSS Center will offer services such as strategic marketing, sales support and business analytics to both our international and domestic customers.

From transactional to highly strategic responsibilities, our GSS India employees will help support the global business growth and accelerate operational excellence. With its high rate of growth, India remains our major focus. With GSS, we will leverage our capabilities, talent and infrastructure in India to better serve our businesses.

Gallery

“Amidst of all opportunities and challenges, how a company survives and sustains is more important than talking merely about the problems. That’s how one succeeds.” - Jason Apter

PROCESS: How do you see the growth of the Indian pharmaceutical and life sciences industry?

"Pharma and Life Sciences Are Growing Well in Asia–Pacific

JASON APTER: The whole of the Asia Pacific market plays an important role in our company’s growth. As a result, we have invested in this region to a great extent in the last few years.

Our company has opened a packaging facility in Bengaluru, a facility in Wuxi, China, which is fully operational and has recently completed a SAFC Hitech precursor manufacturing facility in Taiwan. Therefore, it becomes needless to say that the pharma and life sciences sectors are growing well in the Asia Pacific region including India.

PROCESS: What products and solutions have higher demand in India?

JASON APTER: It is a difficult question to answer as our company offers more than 100,000 products. Hence, it is going to be difficult to have a comparison on the parameters of products. However, there are a few industry segments that have been growing in the country viz. segments such as analytical products, biology products, chemistry products, material science products. All these have a higher demand in India.

(ID:39391530)